Achievements Through Hemovigilance

Faber, Jean‐Claude; Nascimento, Fátima

doi:10.1002/9781118338179.ch24

Cited by 3 publications

(3 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Haemovigilance has been recognized in the last twenty years as one of the most important activities in the field of blood transfusion because of its contribution to increased transfusion safety and improved quality . It is defined as a set of surveillance procedures covering the entire transfusion chain (from the collection of blood and its components to the follow‐up of recipients), which are intended to gather and assess information on unexpected or undesirable events and effects arising from the therapeutic use of labile products, with the ultimate aim of preventing their occurrence or recurrence .…”

Section: Introductionmentioning

confidence: 99%

The International Haemovigilance Network Database for the Surveillance of Adverse Reactions and Events in Donors and Recipients of Blood Components: technical issues and results

Politis

Wiersum²,

Richardson

et al. 2016

Vox Sanguinis

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

The International Haemovigilance Network Database for the Surveillance of Adverse Reactions and Events in Donors and Recipients of Blood Components: technical issues and results

Politis

Wiersum²,

Richardson

et al. 2016

Vox Sanguinis

View full text Add to dashboard Cite

show abstract

“…It is also, therefore, inappropriate to compare reporting rates (which are difficult to define) between countries and haemovigilance systems (Wiersum‐Osselton et al, ). However, many achievements have been made, and most established systems have been able to demonstrate important improvements over time (Faber & Nascimento, ; Steinsvåg et al, ). For example, SHOT has shown a reduction in transfusion‐related deaths from ABO‐incompatible transfusions, TRALI and bacterial infections over time on a background of increased total reports, likely reflecting a true overall improvement in transfusion safety in the UK (Bolton‐Maggs & Cohen, ; Bolton‐Maggs and Poles, ).…”

Section: How Do We Measure the Impact Of Haemovigilance?mentioning

confidence: 99%

International haemovigilance: what have we learned and what do we need to do next?

Wood

Ang

Bisht

et al. 2019

Transfusion Medicine

View full text Add to dashboard Cite

The International Haemovigilance Network (IHN) defines haemovigilance as 'a set of surveillance procedures covering the whole transfusion chain (from the collection of blood and its components to the follow-up of recipients), intended to collect and assess information on unexpected or undesirable effects resulting from the therapeutic use of labile blood products, and to prevent their occurrence or recurrence'. IHN, the International Society of Blood Transfusion and World Health Organization work together to support both developing and established haemovigilance systems. Haemovigilance systems provide valuable data on a range of adverse events related to blood donation and clinical transfusion, from donor syncopal events to transfusion-transmitted infections, immunological complications and the impact of human errors. Harmonised definitions for most adverse reactions have been developed and validated internationally. Definitions of pulmonary complications are again under review. Haemovigilance data have resulted in changes in policy, products and practice, and can complement and inform clinical audit and research, leading to improved blood donor safety, optimised product use and better clinical outcomes after transfusion. However, more work is needed. Not all countries have haemovigilance systems in place. More robust data and careful analysis are required to improve the understanding of the causes, occurrence and clinical outcomes of these events. Wider dissemination of results will facilitate health policy development internationally, and implementation of haemovigilance recommendations will support further important progress in blood safety.

show abstract

“…Donor haemovigilance (DHV) is defined as the systematic monitoring of adverse reactions (ARs) and incidents in the whole chain of blood donor care, with a view to improving the quality and safety of blood donors [1]. Internationally, DHV involves four aspects: complications related to blood donation (donor ARs); errors in donor care (adverse incidents); post-donation information (focusing on aspects relating to donor safety); and counselling and procedures related to unexpected findings [2].…”

Section: Introductionmentioning

confidence: 99%

First donor haemovigilance system at a national level in China: Establishment and improvement

et al. 2023

View full text Add to dashboard Cite

Background and Objectives No systematic study has measured the incidence of adverse reactions (ARs) to blood donation at the national level in China before 2019. The objective of this study was to establish an effective reporting system to collect information on ARs to blood donation in China. Materials and Methods The status of donor haemovigilance (DHV) in blood collection facilities in China was evaluated, and an online DHV system was established to collect data on ARs to blood donation in July 2019. The definitions of ARs were based on the International Society of Blood Transfusion (ISBT) standards. The prevalence and data quality of ARs from 2019 to 2021 were analysed. Results A standard online reporting system has been established for ARs to blood donation. In total, 61, 62 and 81 participating sites were included in this pilot study in 2019, 2020 and 2021, respectively. From July 2019 to December 2021, 21,502 cases of whole‐blood‐related ARs and 1114 cases of apheresis platelet‐related ARs were reported, with an incidence of 3.8‰ and 2.2‰, respectively. Data completeness for key reporting elements improved from 41.7% (15/36) in 2019 to 74.4% (29/39) in 2020. Data quality analysis for the year 2021 yielded similar results as for 2020. Conclusion The construction and continuous improvement of the blood donor safety monitoring system prompted the establishment of the DHV system. Improvements have been made to the DHV system in China, with a significant increase in sentinels and higher data quality.

show abstract

Achievements Through Hemovigilance

Cited by 3 publications

References 3 publications

The International Haemovigilance Network Database for the Surveillance of Adverse Reactions and Events in Donors and Recipients of Blood Components: technical issues and results

The International Haemovigilance Network Database for the Surveillance of Adverse Reactions and Events in Donors and Recipients of Blood Components: technical issues and results

International haemovigilance: what have we learned and what do we need to do next?

First donor haemovigilance system at a national level in China: Establishment and improvement

Contact Info

Product

Resources

About